GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Sloan Ratio %

Mesa Laboratories (Mesa Laboratories) Sloan Ratio % : 5.38% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Mesa Laboratories's Sloan Ratio for the quarter that ended in Dec. 2023 was 5.38%.

As of Dec. 2023, Mesa Laboratories has a Sloan Ratio of 5.38%, indicating the company is in the safe zone and there is no funny business with accruals.


Mesa Laboratories Sloan Ratio % Historical Data

The historical data trend for Mesa Laboratories's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories Sloan Ratio % Chart

Mesa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.24 39.20 -5.29 37.87 -2.65

Mesa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.56 -2.65 -4.57 -5.04 5.38

Competitive Comparison of Mesa Laboratories's Sloan Ratio %

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories's Sloan Ratio % Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's Sloan Ratio % falls into.



Mesa Laboratories Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Mesa Laboratories's Sloan Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2023 )-Cash Flow from Operations (A: Mar. 2023 )
-Cash Flow from Investing (A: Mar. 2023 ))/Total Assets (A: Mar. 2023 )
=(0.93-27.983
--9.494)/661.832
=-2.65%

Mesa Laboratories's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(0.948-43.769
--82.758)/741.769
=5.38%

Mesa Laboratories's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 0.611 (Mar. 2023 ) + -0.549 (Jun. 2023 ) + -1.23 (Sep. 2023 ) + 2.116 (Dec. 2023 ) = $0.9 Mil.
Mesa Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 12.519 (Mar. 2023 ) + 9.939 (Jun. 2023 ) + 9.776 (Sep. 2023 ) + 11.535 (Dec. 2023 ) = $43.8 Mil.
Mesa Laboratories's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -1.026 (Mar. 2023 ) + -0.27 (Jun. 2023 ) + -0.634 (Sep. 2023 ) + -80.828 (Dec. 2023 ) = $-82.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mesa Laboratories  (NAS:MLAB) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Mesa Laboratories has a Sloan Ratio of 5.38%, indicating the company is in the safe zone and there is no funny business with accruals.


Mesa Laboratories Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories (Mesa Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Executives
Brian David Archbold officer: SVP of Continuous Improvement 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder director C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Gary M Owens officer: COO 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys officer: VP Finance, CFO MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin director 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny director ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia officer: SVP Commercial Operations 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/ director 12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan officer: VP Sales & Marketing 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly director
Shiraz Shabanali Ladiwala director C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer director 12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft director 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez director 12100 6TH AVENUE, LAKEWOOD CO 80228

Mesa Laboratories (Mesa Laboratories) Headlines

From GuruFocus

Mesa Labs Announces First Quarter Results

By Marketwired 08-03-2023

Mesa Labs Announces First Quarter Results

By PurpleRose PurpleRose 08-04-2022

Should Investors Worry About Mesa Laboratories Inc's Insider Sells?

By GuruFocus Research GuruFocus Editor 02-10-2023

MESA LABS DECLARES QUARTERLY DIVIDEND

By GuruFocusNews GuruFocusNews 07-06-2022

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

By GuruFocusNews GuruFocusNews 06-27-2022

Mesa Labs Declares Quarterly Dividend

By Marketwired Marketwired 10-01-2021